Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma, Ewing 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphatic Metastasis 1

Interventions

Temozolomide 12 Vincristine 9 Irinotecan 8 Cyclophosphamide 8 cabozantinib 6 X-Rays 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Etoposide 5 regorafenib 4 fludarabine 4 Radiotherapy 4 Phantoms, Imaging 4 Ifosfamide 4 Doxorubicin 4 Radiation 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 irinotecan sucrosofate 2 etoposide phosphate 2 abemaciclib 2 Zoledronic Acid 2 Topotecan 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × alovudine × 1 year × Clear all

NCT04067115 2025-12-17

U01CA236220

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡